Nobiletin restoring β-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats

Neuroscience Letters

Volumn 400, Issue 3, 2006, Pages 230-234

  Matsuzaki, Kentaro ^a   Yamakuni, Tohru ^a   Hashimoto, Michio ^b   Haque, Abdul Md ^b   Shido, Osamu ^b   Mimaki, Yoshihiro ^c   Sashida, Yutaka ^c   Ohizumi, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Alzheimer's disease model rats; Memory; Nobiletin; PKA CREB dependent signaling pathway

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTAMIC ACID; NOBILETIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; FEMALE; HIPPOCAMPUS; LEARNING DISORDER; LONG TERM EXPOSURE; MAZE TEST; MEMORY DISORDER; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; FLAVONES; HIPPOCAMPUS; MEMORY DISORDERS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 33646261868     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.02.077     Document Type: Article

References (19)

1. Abel T., Nguyen P.V., Barad M., Deuel T.A.S., and Kandel E.R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88 (1997) 615-626
2. Frey U., Huang Y.-Y., and Kandel E.R. Effects of cAMP simulate a late stage LTP in hippocampal CA1 neurons. Science 260 (1993) 1661-1664
3. Furukawa K.-I., Sakai K., Watanabe S., Maruyama K., Murakami M., Yamaguchi K., and Ohizumi Y. Goniodomin A induces modulation of actomyosin ATPase activity mediated through conformational change of actin. J. Biol. Chem. 268 (1993) 26026-26031
4. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., and Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 114 (2004) 1624-1634
5. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
6. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J.-I., and Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem. 81 (2002) 1084-1091
7. Kandaswami C., Perkins E., Soloniuk D.S., Drzewiecki G., and Middleton Jr. E. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett. 56 (1991) 147-152
8. Kawahara M., Muramoto K., Kobayashi K., Mori H., and Kuroda Y. Aluminium promotes the aggregation of Alzheimer's amyloid β-protein in vitro. Biochem. Biophys. Res. Commun. 198 (1994) 531-535
9. Liu J. FK506 and cyclosporin: molecular probes for studying intracellular signal transduction. Trends Pharmacol. Sci. 14 (1993) 182-188
10. Minagawa A., Otani Y., Kubota T., Wada N., Furukawa T., Kumai K., Kameyama K., Okada Y., Fujii M., Yao M., Sato T., Ito A., and Kitajima M. The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice. Jpn. J. Cancer Res. 92 (2001) 1322-1328
11. Nagase H., Yamakuni T., Matsuzaki K., Maruyama Y., Kasahara J., Hinohara Y., Kondo S., Mimaki Y., Sashida Y., Tank A.W., Fukunaga K., and Ohizumi Y. Mechanism of neurotrophic action of nobiletin in PC12D cells. Biochemistry 44 (2005) 13683-13691
12. Nitta A., Itoh A., Hasegawa T., and Nabeshima T. beta-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 17 (1994) 63-66
13. Obara Y., Aoki T., Kusano M., and Ohizumi Y. β-Eudesmol induces neurite outgrowth in rat pheochromocytoma cells accompanied by an activation of mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 301 (2002) 803-811
14. Ohizumi Y. Application of physiologically active substances isolated from natural resources to pharmacological studies. Jpn. J. Pharmacol. 73 (1997) 263-289
15. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
16. Tong L., Balazs R., Thornton P.L., and Cotman C.W. β-amyloid peptide at sublethal concentrations down regulates brain-derived neurotrophic factor functions in cultured cortical neurons. J. Neurosci. 30 (2004) 6799-6809
17. Tong L., Thornton P.L., Balazs R., and Cotman C.W. β-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J. Biol. Chem. 276 (2001) 17301-17306
18. Urani A., Romieu P., Roman F.J., Yamada K., Noda Y., Kamei H., Manh T.H., Nagai T., Nabeshima T., and Maurice T. Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1-40) protein. Eur. J. Pharmacol. 486 (2004) 151-161
19. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., and Shelanski M. Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13217-13221